Skip to main content

toppbild-press-1551x278.jpg

Press

Interview with CEO Anna Ljung

Link to video »
  • All pressreleases
  • Regulatory
2022-08-09 | Press release
Moberg Pharma´s interim report January - June 2022
2022-08-04 | Press release
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel
2022-06-30 | Press release
New number of shares and votes in Moberg Pharma AB (publ)

Read more »

2022-08-09 | Press release
Moberg Pharma´s interim report January - June 2022
2022-08-04 | Press release
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel
2022-06-30 | Press release
New number of shares and votes in Moberg Pharma AB (publ)

Read more press releases »

Latest report

2022-08-09 Moberg Pharma´s interim report January - June 2022

Contact for press och media:

Anna Ljung, CEO
Phone: +46 8 522 307 08
Email: anna.ljung@mobergpharma.se
 

Subscribe

Get our latest press releases and reports

 

Calendar/presentations

Next calendar event: 2022-11-08 Interim report for January - September 2022

IMAGE BANK  »